Orphanet Journal of Rare Diseases | Nutritional Status and Body Composition Analysis in HGPS Children

Recommend:

This study systematically evaluated the growth, nutritional status, and body composition of children with HGPS, revealing abnormal fat and muscle distribution, providing important evidence for nutritional intervention and treatment strategies.

 

Literature Overview

This article, titled 'Nutritional Status and Body Composition in Children with Hutchinson-Gilford Progeria Syndrome', published in Orphanet Journal of Rare Diseases, reviews and summarizes the growth retardation, malnutrition, and abnormal body composition in HGPS children. It also emphasizes the importance of nutritional intervention and body composition monitoring in disease management. The study systematically analyzed the differences between 8 HGPS children and healthy controls using DXA scans, dietary surveys, and laboratory tests, providing data support for nutritional and metabolic interventions.

Background Knowledge

Hutchinson-Gilford Progeria Syndrome (HGPS) is an extremely rare genetic disorder characterized by premature aging, with a global prevalence of approximately 1 in 20 million. It is caused by mutations in the LMNA gene, leading to abnormal accumulation of the progerin protein, which affects nuclear structure and gene expression regulation. HGPS children typically exhibit typical phenotypes such as skin sclerosis, growth retardation, bone abnormalities, and fat distribution disorders within the first year of life. There is currently no cure for this disease, and patients have an average life expectancy of about 14.5 years, with cardiovascular disease being the primary cause of death. Although previous studies have assessed total fat mass and lean body mass in HGPS children, systematic analysis of regional fat and muscle distribution remains lacking. Therefore, this study, using DXA scans and dietary assessments, is the first to systematically analyze body composition changes in HGPS children, providing a basis for personalized nutritional and metabolic intervention strategies.

 

Can be used before designing experiments to predict potential phenotypes caused by gene knockout.

Learn More

 

Methods and Experiments

The study included 8 HGPS children (≥3 years) and 18 healthy controls, undergoing physical exams, dietary surveys, and laboratory testing. WHO growth curves were used to plot weight and height changes, while DXA scans were used to analyze bone density, fat distribution, and muscle mass. Dietary assessments were conducted using a 24-hour recall method, with energy and nutrient intake calculated via NutriStar software. Laboratory tests included hemoglobin, albumin, prealbumin, lipid metabolism, bone metabolism markers, IGF-1, and binding proteins. Data were analyzed using SPSS 26.0, and graphs were generated using Origin 2021.

Key Findings and Insights

• Weight and height Z-scores in HGPS children were significantly lower than in healthy controls starting at two months of age, indicating severe growth retardation
• Among the 8 HGPS children, 4 had adequate energy intake, with total intake at 91±39% of BMR
• All children showed insufficient intake of vitamin D, calcium, phosphorus, and magnesium, suggesting targeted supplementation is needed
• DXA scans showed significantly reduced bone mineral density (Z-score -2.82±1.46), with 5 children having BMD below -2SD
• Abnormal fat distribution was observed, characterized by increased visceral fat and decreased subcutaneous fat, with T/L and A/G fat ratios exceeding the 95th percentile
• Significant reduction in muscle mass, with MMI, ASMI, ULSMI, and LLSMI all below -2SD
• All children showed joint deformities and bone resorption, with 3 having hip dislocation, indicating that strenuous exercise should be avoided

Research Implications and Future Directions

This study is the first to systematically analyze body composition characteristics in HGPS children, revealing abnormal fat and muscle distribution and providing scientific evidence for nutritional intervention and body composition monitoring. The study recommends a high-protein, high-calorie, high-fiber diet supplemented with vitamin D, calcium, and zinc to support growth and muscle maintenance. In addition, resistance training and regular body composition assessments may help improve metabolic and cardiovascular risks. Larger sample sizes and longitudinal studies are needed to validate the effects of nutritional interventions and explore the mechanisms of growth hormone in HGPS.

 

A practical tool for rapidly mapping DNA or RNA sequences to the genome.

Learn More

 

Conclusion

Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare progeroid disorder caused by LMNA gene mutations. Children exhibit significant growth retardation, reduced bone mineral density, and abnormal fat distribution. This study, through comparison with healthy controls, reveals that HGPS children show significantly reduced weight and height Z-scores as early as two months after birth, with both muscle mass and bone density below -2SD. Dietary surveys indicate inadequate energy and nutrient intake in some children, with widespread deficiencies in vitamin D, calcium, phosphorus, and magnesium. DXA analysis shows abnormal fat distribution, characterized by increased visceral fat and decreased subcutaneous fat, with T/L and A/G fat ratios exceeding the 95th percentile, which may be associated with increased cardiovascular risk. The study recommends a high-protein, high-calorie, high-fiber diet supplemented with vitamin D and calcium to improve bone and muscle quality. Strenuous activity should be avoided to reduce hip dislocation risk, and resistance training may aid in muscle preservation. This study provides data support for personalized nutritional interventions and lays the foundation for future body composition monitoring and metabolic regulation research.

 

Qinmei Yu, Jingjing Wang, Haidong Fu, and Jianhua Mao. A study on the nutritional status and body composition of children with Hutchinson–Gilford progeria syndrome. Orphanet Journal of Rare Diseases.